Abstract:Major 5'-terminally deleted (5'TD) RNA forms of group-B coxsackievirus (CVB-5'TD) has been associated with myocarditis in both mice and humans. Although it is known that interferon-β (IFN-β) signaling is critical for an efficient innate immune response against CVB-induced myocarditis, the link between CVB-5'TD RNA forms and type I IFN signaling in cardiomyocytes remains to be explored. In a mouse model of CVB3/28-induced myocarditis, major early-emerging forms of CVB-5'TD RNA have been characterized as replicative viral populations that impair IFN-β production in the heart. Synthetic CVB3/28 RNA forms mimicking each of these major 5'TD virus populations were transfected in mice and have been shown to modulate innate immune responses in the heart and to induce myocarditis in mice. Remarkably, transfection of synthetic viral RNA with deletions in the secondary structures of the 5'-terminal CVB3 RNA domain I, modifying stem-loops "b", "c" or "d", were found to impair IFN-β production in human cardiomyocytes. In addition, the activation of innate immune response by Poly(I:C), was found to restore IFN-β production and to reduce the burden of CVB-5'TD RNA-forms in cardiac tissues, thereby reducing the mortality rate of infected mice. Overall, our results indicate that major early-emerging CVB3 populations deleted in the domain I of genomic RNA, in the 5' noncoding region, modulate the activation of the type I IFN pathway in cardiomyocytes and induce myocarditis in mice. These findings shed new light on the role of replicative CVB-5'TD RNA forms as key pathophysiological factors in CVB-induced human myocarditis. Myocarditis is an inflammatory disease of the heart. Viruses or post-viral immune mediated response are the main causes of myocarditis. Human group B enteroviruses, specifically Coxsackievirus B3 (CVB3), are common infectious causes of acute myocarditis in the young. Early emergence and maintenance of major 5'terminally deleted RNA forms of CVB have been associated with acute and chronic myocarditis in both mice and humans. To achieve viral genome maintenance in the cardiac cells, viruses could modulate innate immunity activation. Here, we report on major early-emerging CVB3 populations deleted in the 5'non-coding region of viral genomic RNA that modulate the activation of the type I interferon pathway in cardiomyocytes and cause myocarditis in mice. Activating the innate immune sensors after CVB3 infection protects mice from CVB3-induced myocarditis and shall promote further studies in immunotherapies in viral acute and chronic myocarditis.

MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication Via Targeting Tripartite Motif Protein 25

NMI Facilitates Influenza A Virus Infection by Promoting Degradation of IRF7 Through TRIM21.

MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.

Cardiac Mir-19A/19b Was Induced and Hijacked by CVB3 to Facilitate Virus Replication Via Targeting Viral Genomic RdRp-encoding Region.

MicroRNA-223 Promotes Type I Interferon Production in Antiviral Innate Immunity by Targeting Forkhead Box Protein O3 (FOXO3)

TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury Via Interacting with MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production

Analysis of microRNA expression profiles in CVB3-induced myocarditis

MicroRNA-20b Suppresses the Expression of ZFP-148 in Viral Myocarditis

MicroRNA-33/33* Inhibit the Activation of MAVS Through AMPK in Antiviral Innate Immunity

MicroRNA-34a Aggravates Coxsackievirus B3-Induced Apoptosis of Cardiomyocytes through the SIRT1-p53 Pathway.

MicroRNA-22-3p displaces critical host factors from the 5′ UTR and inhibits the translation of Coxsackievirus B3 RNA

Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1

Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis

Association of TRIM22 with the Type 1 Interferon Response During Primary Human Cytomegalovirus Infection in THP-1 Macrophages

Investigating TIP30-Mediated regulation of mTORC1 signaling as a therapeutic strategy for coxsackievirus B3-Induced viral myocarditis

MicroRNA-30c Modulates Type I IFN Responses to Facilitate Porcine Reproductive and Respiratory Syndrome Virus Infection by Targeting JAK1

Gga-Mir-27b-3p Enhances Type I Interferon Expression and Suppresses Infectious Bursal Disease Virus Replication Via Targeting Cellular Suppressors of Cytokine Signaling 3 and 6 (SOCS3 and 6).

MicroRNA-30c is utilized by PRRSV in immune evasion through targeting JAK1 in the type I interferon signaling pathway (VIR5P.1153)

MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis.